Adaltis Inc.

Adaltis Inc.

April 29, 2009 10:38 ET

Notice of Adaltis Annual Shareholders Meeting and First Quarter 2009 Results

MONTREAL, QUEBEC--(Marketwire - April 29, 2009) - Adaltis Inc. (TSX:ADS), an international in vitro diagnostic company, today announced that the Company will hold its annual meeting of shareholders on Tuesday, May 5, 2009 at 11:00 a.m. ET. The meeting will be held at the Palais des congres de Montreal, room 513-AB, located at 159 Saint-Antoine St. West, Montreal, Quebec.

In addition, the Company's 2009 first quarter summary results will be released prior to the beginning of the annual shareholders meeting on May 5, 2009.

About Adaltis

Adaltis is an international in vitro diagnostic company with a mission to become a leading provider of in vitro diagnostic products in emerging markets, with a particular focus on China.

With the strategic advantage of its "state of the art" reagent manufacturing facility located in Shanghai, China, a complete IVD product offering targeting emerging markets, and a strong international sales and distribution platform, Adaltis is able to manufacture high-quality products in a low-cost GMP environment, in order to service existing markets in Europe, while providing a platform to penetrate the high-growth Chinese in vitro diagnostic market.

Adaltis is registered in Montreal, with offices in China, Italy, Mexico, and other parts of the world.

Contact Information